Your browser doesn't support javascript.
loading
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.
Wilkerson, Julia; Abdallah, Kald; Hugh-Jones, Charles; Curt, Greg; Rothenberg, Mace; Simantov, Ronit; Murphy, Martin; Morrell, Joseph; Beetsch, Joel; Sargent, Daniel J; Scher, Howard I; Lebowitz, Peter; Simon, Richard; Stein, Wilfred D; Bates, Susan E; Fojo, Tito.
Afiliação
  • Wilkerson J; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Abdallah K; AstraZeneca, Gaithersburg, MD, USA.
  • Hugh-Jones C; Sanofi US, Bridgewater, NJ, USA.
  • Curt G; AstraZeneca, Gaithersburg, MD, USA.
  • Rothenberg M; Pfizer Inc, New York, NY, USA.
  • Simantov R; Pfizer Inc, New York, NY, USA.
  • Murphy M; Project Data Sphere LLC, Cary, NC, USA.
  • Morrell J; Project Data Sphere LLC, Cary, NC, USA.
  • Beetsch J; Celgene Corporation, Summit, NJ, USA.
  • Sargent DJ; Mayo Medical Center, Rochester, MN, USA.
  • Scher HI; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lebowitz P; Janssen, the Pharmaceutical Companies of Johnson & Johnson, New Brunswick, NJ, USA.
  • Simon R; Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Stein WD; Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel.
  • Bates SE; Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA.
  • Fojo T; Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA. Electronic address: atf2116@cumc.columbia.edu.
Lancet Oncol ; 18(1): 143-154, 2017 01.
Article em En | MEDLINE | ID: mdl-27979599

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article